greeksoup/ stock research
Stock research / United States / PBH / Q2 FY2024

Prestige Consumer Healthcare (PBH) Q2 FY2024 earnings: revenue $286 million, down 1.0% on the year

Prestige Consumer Healthcare Inc. (PBH) reported revenue of $286 million for Q2 FY2024, the quarter ended 30 September 2023, down 1.0% on the same quarter a year earlier. Net income was $54 million, up 5.0% on the year, and diluted earnings per share $1.07. The figures are the company's own, from the 10-Q it filed with the SEC on 2 November 2023.

Revenue$286 milliondown 1.0%
Net income$54 millionup 5.0%
Diluted EPS$1.07
QuarterQ2 FY2024ended 30 September 2023

The quarter, against the one before and a year earlier

LineQ2 FY2024Quarter beforeA year earlierChange on the year
Revenue286n/an/an/a
Cost of revenue126n/an/an/a
Gross profit160n/an/an/a
Gross margin55.9%n/an/a
Operating income88.2n/an/an/a
Operating margin30.8%n/an/a
Interest expense17.6n/an/an/a
Income tax16.9n/an/an/a
Net income53.6n/an/an/a
Net margin18.7%n/an/a
Diluted EPS$1.07n/an/an/a
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ2 FY2024Quarter beforeA year earlierChange on the year
Operating cash flow62.5n/an/an/a
Capital expenditure2.9n/an/an/a
Free cash flow59.5n/an/an/a
Free cash flow margin20.8%n/an/a
Cash from investing-2.9n/an/an/a
Cash from financing-53.5n/an/an/a
Depreciation and amortisation7.6n/an/an/a
Share-based compensation3.7n/an/an/a
Buybacks0.0n/an/an/a
Diluted shares, weighted50mn/an/an/a
Shares outstanding at period end50mn/an/an/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ2 FY2024Quarter beforeA year earlierChange on the year
Shareholders' equity1,536n/an/an/a
Debt1,263n/an/an/a
Operating lease liabilities6.6n/an/an/a
Finance lease liabilities0.2n/an/an/a
Other liabilities527n/an/an/a
Total liabilities and equity3,333n/an/an/a
Fixed assets70.7n/an/an/a
Goodwill527n/an/an/a
Intangible assets2,328n/an/an/a
Cash and equivalents60.1n/an/an/a
Receivables158n/an/an/a
Inventory161n/an/an/a
Other assets27.3n/an/an/a
Total assets3,333n/an/an/a

Questions

What was Prestige Consumer Healthcare's revenue in Q2 FY2024?

Prestige Consumer Healthcare (PBH) reported revenue of $286 million for Q2 FY2024, the quarter ended 30 September 2023, down 1.0% on the same quarter a year earlier.

How much did Prestige Consumer Healthcare earn in Q2 FY2024?

Net income for Q2 FY2024 was $54 million, up 5.0% on the year, and diluted earnings per share $1.07.

When did Prestige Consumer Healthcare report Q2 FY2024 results?

Prestige Consumer Healthcare filed its 10-Q for the quarter ended 30 September 2023 with the SEC on 2 November 2023.

Quarterly results, the last 12 quarters

Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026 *Q1 FY2027
Revenue286283277267284290297250274283282266
Cost of revenue126125125121126129127109123126135130
Gross profit160158152146157161170140152157146136
Gross margin56%56%55%55%55%55%57%56%55%56%52%51%
Operating income88.286.882.272.084.392.088.471.879.782.575.552.5
Operating margin31%31%30%27%30%32%30%29%29%29%27%20%
Interest expense17.616.6n/a13.112.311.5-35.1n/an/an/an/an/a
Net income53.653.049.549.154.461.050.147.542.246.753.929.2
Net margin19%19%18%18%19%21%17%19%15%16%19%11%
Diluted EPS$1.07$1.06$0.98$0.98$1.09$1.22$1.00$0.95$0.86$0.97$1.13$0.61
Operating cash flow62.571.566.954.869.865.161.879.057.578.342.870.8
Capital expenditure2.92.03.11.22.01.63.50.82.13.05.23.7
Free cash flow59.569.563.853.667.863.558.478.255.475.337.667.1
Buybacks0.00.00.026.011.82.411.334.875.045.80.70.0
Shares outstanding50m50m50m50m49m50m49m49m48m47m47m47m
Filing10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 30 September 2023, filed 2 November 2023, accession 0001295947-23-000034: the filing on EDGAR. All of Prestige Consumer Healthcare Inc.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install